PD11 - Omalizumab in children: experience in the Immunoallergology Department

PD11 - Omalizumab in children: experience in the Immunoallergology Department

Bibliographic Details
Main Authors:	Aguiar, Rita, Silva, Pedro, Cabral Duarte, Fátima, Mendes, Ana, Célia Costa, Ana, Pereira, Manuel Barbosa
Format:	Online
Language:	English
Published:	BioMed Central 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082038/

Similar Items

Poster 1012: Safety and efficacy of omalizumab in 10 children with asthma and other allergic comorbidities
by: Aguiar, Rita, et al.
Published: (2014)

Frequency of LTP (Pru p 3) and Profilin (Pru p 4) sensitisation in 1052 patients referenced to an immunoallergology department in Lisbon
by: Pereira Santos, M Conceição, et al.
Published: (2014)

Efficacy and safety of omalizumab treatment to facilitate successful oral desensitisation in high-risk milk-allergic patients
by: Aguiar, Rita, et al.
Published: (2015)

Allergy assessment in adult Portuguese cohort with eosinophilic esophagitis
by: Aguiar, Rita, et al.
Published: (2015)

Eosinophilic esophagitis in Portuguese children: clinical and allergological characterisation
by: Marcelino, João, et al.
Published: (2015)

The use of recombinant fish parvalbumin Gad c 1 in the characterisation of fish allergic patients
by: Cabral Duarte, Fátima, et al.
Published: (2015)

Allergic reactions to insulin: a case report
by: Aguiar, Rita, et al.
Published: (2014)

Poster 1020: Efficacy and safety of sublingual specific immunotherapy with Pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months
by: Costa, Ana Célia, et al.
Published: (2014)

Omalizumab in Children
by: Licari, Amelia, et al.
Published: (2014)

Aspirin desensitization for urgent endovascular treatment of the aneurysm
by: Aguiar, Rita, et al.
Published: (2014)

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
by: Pennington, Luke F., et al.
Published: (2016)

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
by: Valle, Solange Oliveira Rodrigues, et al.
Published: (2015)

Omalizumab treatment in brittle asthma
by: Skiepko, Roman, et al.
Published: (2014)

Omalizumab—A Review
by: Godse, Kiran, et al.
Published: (2015)

Omalizumab: Clinical Use for the Management of Asthma
by: Thomson, Neil C., et al.
Published: (2012)

Omalizumab for chronic urticaria in Latin America
by: Wilches, Paul, et al.
Published: (2016)

Uriticaria and angioderma after ingestion of grapes
by: Costa, Ana Célia, et al.
Published: (2011)

Metabolomic applied to omalizumab effect in severe asthmatics – a preliminary result
by: Loureiro, Cláudia Chaves, et al.
Published: (2013)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
by: S. M. Snelder, et al.
Published: (2017-07-01)

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
by: Yalcin, Arzu Didem, et al.
Published: (2012)

280 Use of Omalizumab in Chronic Moderate to Severe Persistent Asthma-an Indian Experience
by: Ansari, Qamar, et al.
Published: (2012)

Omalizumab in an allergology clinic: real life experience and future developments
by: Kupczyk, Maciej, et al.
Published: (2014)

Specific oral tolerance induction (SOTI) to cow’s milk in an adult patient with anaphylaxis symptoms
by: Dias, José Geraldo, et al.
Published: (2011)

Update on optimal use of omalizumab in management of asthma
by: Pelaia, Girolamo, et al.
Published: (2011)

T cell activity in successful treatment of chronic urticaria with omalizumab
by: Sánchez-Machín, Inmaculada, et al.
Published: (2011)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
by: Godse, Kiran V
Published: (2011)

279 Near-Fatal Asthma Treated with Omalizumab
by: Contreras Contreras, Elvia Angelica, et al.
Published: (2012)

Omalizumab: clinical use for the treatment of an adolescent with difficult asthma
by: De Castro, Giovanna, et al.
Published: (2013)

271 Evaluation of Adverse Events Associated to Administration of Omalizumab
by: Gomez, R. Maximiliano, et al.
Published: (2012)

269 Refractory Chronic Urticaria Treated with Omalizumab
by: Saenz, Martinez, et al.
Published: (2012)

Omalizumab as successful treatment option in severe peanut allergy
by: Dehlink, E, et al.
Published: (2013)

274 Vasculitic Urticaria Treated with Omalizumab. Case Report
by: Ramírez Del Pozo, María Elena, et al.
Published: (2012)

Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria
by: Nam, Young-Hee, et al.
Published: (2012)

Effects of omalizumab on chronic urticaria not responding to recommended therapy
by: Hébert, Jacques, et al.
Published: (2012)

Omalizumab, an anti-immunoglobulin E antibody: state of the art
by: Incorvaia, Cristoforo, et al.
Published: (2014)

Omalizumab in recurring larynx angioedema: a case report
by: Ozturk, Ayse Bilge, et al.
Published: (2014)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
by: Labrador-Horrillo, Moises, et al.
Published: (2015)

Cytomegalic hepatitis in a patient receiving omalizumab
by: Gonçalves, R., et al.
Published: (2016)

A review of omalizumab for the management of severe asthma
by: Lin, Ching-Hsiung, et al.
Published: (2016)

Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature
by: Ghazanfar, Misbah Nasheela, et al.
Published: (2015)